Search

Search Constraints

You searched for: Author/Creator Grube, Marcel

Search Results

1. 2022-RA-894-ESGO Endometrioid ovarian carcinoma – real world evidence from a large transatlantic team initiative: First results of the LEOPARD study. (20th October 2022)

2. 2022-RA-995-ESGO Independent prognostic significance of substantial lymphovascular space invasion (LVSI) in a consecutive series of primary LVSI-positive endometrial carcinoma (EC). (20th October 2022)

3. 21/#810 A current perspective on endometrial carcinoma (EC) risk classification: results from an European multicentre initiative. (4th December 2022)

4. CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Issue 5 (26th December 2022)

6. L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors: Impact on Tumor Recurrence and Potential Role in Tumor Progression. (28th May 2023)

7. O031/#777 Lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease: results from the leopard trial. (4th December 2022)

8. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas. Issue 4 (7th February 2022)